!!Xin Lu - Curriculum Vitae
\\
__Education:__
\\
*1991  PhD in Cell and Molecular Biology, Imperial Cancer Research Fund and   University College London, London, UK\\
*1985 MSc in Cell and Molecular Biology, Cancer Institute, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, P. R. China\\
*1982  BSc in Biochemistry, Sichuan University, P.R. China
\\
__Committees and Associations:__
\\ \\
__1. Scientific Advisory and Selection Committees:__
\\
*2021  Istituto Toscano Tumori (ITT) Italy ISAB member\\
*2010 - present Medical Sciences Division Board Member, University of Oxford, UK\\
*2013 - present Academy of Medical Sciences, Selection Committee \\
*2011  Carcinogenesis Prize Selection Committee, UK\\
*2010 Molecular Medicine Advisory/Review Panel Member, The Nordic Centre of Excellence Programme\\
*2008 - 2010  Scientific Advisory/Review Board Member, Institute of Molecular and Cell Biology, Singapore \\
*2006 - 2009  Advisory Panel Member, CR-UK China Fellowships Programme, UK
\\
__2.          Institute Review Committees__
\\
*2020  The ‘Genes and Society’ and ‘Neuroscience’ Research Themes Review for   Trinity College Dublin\\
*2014-2016 International Review, Peking University School of Life Sciences, China\\
*2010-present International Review, Tsinghua University, China \\
*2009 MRC Epigenetics, Development and Cancer Section, Imperial College, London, UK\\
*2008-present International review, Chinese Academy of Science, China\\
*2008  MRC Induced Pluripotent Stem Cells Review Board, UK\\
*2008  MRC Models of Disease Panel, UK\\
*2008  MRC Genome Damage and Stability Centre Review, UK\\
*2008 Cesar Milstein Chair Electoral Board, University of Oxford, UK\\
*2007 - 2008 MRC Oncology Showcase Pilot Industry Collaboration Award Scheme, UK
\\
__3. Grant Committees__
\\
*2020 Swedish Research Council Review Panel for “Grants for Distinguished Professors”\\
*2012 - present European Research Council (ERC) Consolidator Panel\\
*2011 - 2015 Cancer Research UK New Investigator Awards Panel, UK\\
*2007 Committee Member, Deutsche Forschungsgemeinschaft (DFG), Center of Excellence, Germany\\
*2006 - 2011 MRC Molecular and Cellular Medicine Board (MCMB), UK \\
*2006 - 2009 Chair of Cancer Biology Review Panel, Academy of Finland\\
*2006 - 2009 Several International PhD Examination Committees in Lausanne and Stockholm\\
*2006  Hong Kong Research Council Biomedical Panel, China\\
*2005 - 2006 Chairman, Chinese Life Science Society in UK, UK\\
*2004 - 2007 Scientific Grant Committee Member, Association for International Cancer Research (AICR), UK
\\
__4. Editorial Board Memberships:__
\\
*2014 - present Cell Death and Differentiation, Receiving Editor\\
*2009 - present Cell Death and Disease, Editorial Board Member \\
*2008 - present Oncogene, Receiving Editor\\
*2008 - 2011 Carcinogenesis, Editorial Board Member \\
*2005 - 2011 Cell Research, Editorial Board Member
\\
__5. Meetings Organised (2007-2016):__
\\
*2016 National Cancer Research Institute (NCRI) Conference Committee Member \\
*2016 Nature Conference, Nuclear Reprogramming and the Cancer Genome, San Diego\\
*2015 ICG-10: the 10th International Conference of Cancer Genomics, Shenzhen \\
*1st CRUK International Oesophageal Cancer Symposium\\
*2014 Chinese Academy of Sciences-Nature Conference: Nuclear Reprogramming and Cancer Epigenetics, Guangzhou \\
*Joint Conference of ICG-9 and the 3rd Shenzhen International Biotechnology Innovation Forum & Expo, Shenzhen \\
*Single Cell Sequencing Workshop, Oxford, UK \\
*2013  Ludwig-Nature Conference: Nuclear Reprogramming of the Cancer Genome, Oxford, UK \\
*2011  Cell Polarity in Health and Disease, Oxford, UK\\
*3rd Sino-British Frontier Workshop of Cancer Biology, Shanghai, China\\
*2010 2nd Sino-British Frontier Workshop of Cancer Biology, Shanghai, China\\
*2008  14th International p53 Workshop, Shanghai, China\\
*Chinese Academy of Science – Morningside Symposium, Kunming, China\\
*Keystone Symposium – Stem Cells, Cancer and Ageing, Singapore \\
*1st Sino-British Frontier Workshop of Cancer Biology, Shanghai, China\\
*2007 University of Oxford Medical Sciences Division, Science Day, Development, Differentiation & Malignancy, Oxford, UK\\
*Mdm2 Workshop, Boston, USA
\\
__Patents:__
\\
*LUD5649 Suppressor Genes     04/8/00\\
*LUD5868 iASPP       07/10/02  \\
*LUD5829 iASPP Polypeptide     07/10/02\\
*LUD6098 iASPP Phosphorylation and Metastatic Potential  03/02/12\\ \\